Acute leukaemia, Acute lymphoblastic leukaemia (ALL), All cancer types, Blood cancers, Leukaemia
Results
Phase 2
This trial used blinatumomab to reduce the small number of leukaemia cells left in the blood after treatment for B cell acute lymphoblastic leukaemia.
This trial was open for people to join between 2010 and 2013. The researchers published the results in 2018.
Recruitment start: 1 December 2010
Recruitment end: 20 December 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Adele Fielding
Amgen
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 8 August 2019
CRUK internal database number: 8795
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
